Headlines

Zoetis Inc. (ZTS) Q4 2025 (USD): Adj, EPS 1. 48 (exp. 1.40), Revenue 2.39bln (exp. 2.36bln); FY adj. EPS view 7.00-7.10 (exp. 6.83)

Newsquawk Staff ·

Zoetis Inc. (ZTS) Q4 2025 (USD): Adj, EPS 1. 48 (exp. 1.40), Revenue 2.39bln (exp. 2.36bln); FY adj. EPS view 7.00-7.10 (exp. 6.83)

What it means

Zoetis Inc. reported better-than-expected Q4 results, beating both EPS and revenue estimates, which could signal strong underlying demand for its products. The upward revision on its full-year EPS outlook further supports a positive growth trajectory and may instill confidence in investors, particularly within the pharmaceuticals sector. This earnings beat could also have implications for related stocks in the biotech and life sciences space.

Related headlines